Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Motivational Interviewing to Prevent Suicide in High Risk Veterans

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Department of Veterans Affairs
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT01544127
First received: February 28, 2012
Last updated: July 16, 2014
Last verified: July 2014

February 28, 2012
July 16, 2014
July 2012
July 2016   (final data collection date for primary outcome measure)
Severity of Suicidal Ideation [ Time Frame: Six months ] [ Designated as safety issue: No ]
The severity of suicidal ideation will be measured using the Beck Scale for Suicidal Ideation (SSI) at baseline, 1, 3, and 6 months after discharge.
Same as current
Complete list of historical versions of study NCT01544127 on ClinicalTrials.gov Archive Site
Treatment Engagement [ Time Frame: Six months ] [ Designated as safety issue: No ]
Treatment engagement will be measured using the Treatment Services Review-6 (TSR-6) at baseline, 1, 3, and 6 months after discharge.
Same as current
Not Provided
Not Provided
 
Motivational Interviewing to Prevent Suicide in High Risk Veterans
Motivational Interviewing to Prevent Suicide in High Risk Veterans

The purpose of study is to test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized veterans at high risk for suicide.

Veterans who receive health care from the VA are at elevated risk for suicide, and the number of veterans at high risk may be growing. Although the months following discharge from psychiatric hospitalization are a period of acute risk for veterans, there is a dearth of empirically supported treatments tailored to psychiatric inpatients and no studies examining treatments for psychiatrically hospitalized veterans. This randomized controlled trial will test the efficacy of an adaptation of Motivational Interviewing to Address Suicidal Ideation (MI-SI) on the severity of suicidal ideation in psychiatrically hospitalized veterans at high risk for suicide. Participants will be recruited from the Acute Psychiatric Inpatient Unit at the Syracuse VA Medical Center. To meet high-risk criteria, veterans must score over two on the Beck Scale for Suicidal Ideation (SSI), which is prospectively predictive of death by suicide. Participants will complete a screening assessment to confirm eligibility and a baseline assessment of risk factors for suicide. They will be randomized to receive Motivational Interviewing to Address Suicidal Ideation (MI-SI) plus treatment as usual (TAU), or TAU alone. The MI-SI group will receive two sessions of MI-SI during hospitalization and one telephone booster session after discharge. Participants in both conditions will be asked to complete telephone follow-up interviews at 1, 3, and 6 months after discharge. Change in the severity of suicidal ideation will be measured using the SSI.

Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
  • Suicidal Ideation
  • Treatment Engagement
Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)
1 or 2 in-person MI-SI sessions (50 mins.) on an inpatient unit, plus a telephone follow-up MI-SI session (30-50 mins)
  • Experimental: Arm 1
    Motivational Interviewing to Address Suicidal Ideation (MI-SI)
    Intervention: Behavioral: Motivational Interviewing to Address Suicidal Ideation (MI-SI)
  • No Intervention: Arm 2
    Treatment as Usual (TAU)
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
112
July 2016
July 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • veteran status,
  • admitted to psychiatric inpatient unit,
  • age 18 and over,
  • English speaking,
  • able to understand the study and provide informed consent,
  • clinically cleared to participate by unit staff,
  • receive health care from a VA facility in upstate NY,
  • at increased risk for suicide (Beck Scale for Suicidal Ideation [SSI] > 2)

Exclusion Criteria:

  • current psychosis,
  • current mania,
  • dementia,
  • prisoner status,
  • being inaccessible and discharged from the unit less than 48 hours after being identified by study staff
Both
18 Years and older
No
Contact: Lynn M Knickerbocker (315) 425-4400 ext 56566 lynn.knickerbocker@va.gov
Contact: Andrea Hahn (315) 425-4400 ext 53607 andrea.hahn@va.gov
United States
 
NCT01544127
MHBA-20-11S, K2CX00064
Yes
Department of Veterans Affairs
Department of Veterans Affairs
Not Provided
Principal Investigator: Peter Britton, PhD MS Syracuse VA Medical Center, Syracuse, NY
Department of Veterans Affairs
July 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP